Use of a novel and highly selective oxytocin receptor antagonist to characterize uterine contractions in the rat. (Q34613868)

3 August 2017

title

Use of a novel and highly selective oxytocin receptor antagonist to characterize uterine contractions in the rat. (English)

1 reference

3 August 2017

1 reference

Gerald P McCafferty

1 reference

3 August 2017

Mark A Pullen

1 reference

3 August 2017

Charlene Wu

1 reference

3 August 2017

Richard M Edwards

1 reference

3 August 2017

Michael J Allen

1 reference

3 August 2017

Patrick M Woollard

1 reference

3 August 2017

Alan D Borthwick

1 reference

3 August 2017

John Liddle

1 reference

3 August 2017

Deirdre M B Hickey

1 reference

3 August 2017

David P Brooks

1 reference

3 August 2017

Timothy D Westfall

1 reference

3 August 2017

publication date

29 March 2007

1 reference

American Journal of Physiology - Regulatory, Integrative and Comparative Physiology

3 August 2017

published in

1 reference

3 August 2017

volume

293

1 reference

3 August 2017

1 reference

3 August 2017

page(s)

R299-305

1 reference

Development of orally active oxytocin antagonists: studies on 1-(1-[4-[1-(2-methyl-1-oxidopyridin-3-ylmethyl)piperidin-4-yloxy]-2- methoxybenzoyl]piperidin-4-yl)-1,4-dihydrobenz[d][1,3]oxazin-2-one (L-372,662) and related pyridines

3 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00057.2007

Paracrine oxytocin and estradiol demonstrate a spatial increase in human intrauterine tissues with labor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00057.2007

Synthesis of oxytocin in amnion, chorion, and decidua may influence the timing of human parturition

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00057.2007

Pharmacology of (2S,4Z)-N-[(2S)-2-hydroxy-2-phenylethyl]-4-(methoxyimino) -1-[(2'-methyl[1,1'-biphenyl]-4-yl)carbonyl]-2-pyrrolidinecarboxamide, a new potent and selective nonpeptide antagonist of the oxytocin receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00057.2007

Plasma, membrane receptors regulating myometrial contractility and their hormonal modulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00057.2007

The effect of the oxytocin antagonist atosiban on preterm uterine activity in the human.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00057.2007

Treatment of preterm labor with the oxytocin antagonist atosiban

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00057.2007

New perspectives for the effective treatment of preterm labor

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00057.2007

Intraamniotic deamino(D-Arg8)-vasopressin: prolonged effects on ovine fetal urine flow and swallowing

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00057.2007

Human myometrium during pregnancy contains and responds to V1 vasopressin receptors as well as oxytocin receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00057.2007

Design of peptide oxytocin antagonists with strikingly higher affinities and selectivities for the human oxytocin receptor than atosiban

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00057.2007

Double-blind, randomized, controlled trial of atosiban and ritodrine in the treatment of preterm labor: a multicenter effectiveness and safety study

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00057.2007

Effect of the oxytocin antagonist atosiban (1-deamino-2-D-tyr(OET)-4-thr-8-orn-vasotocin/oxytocin) on nocturanl myometrial contractions, maternal cardiovascular function, transplacental passage, and fetal oxygenation in the pregnant baboon during th

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00057.2007

Barusiban, a new highly potent and long-acting oxytocin antagonist: pharmacokinetic and pharmacodynamic comparison with atosiban in a cynomolgus monkey model of preterm labor

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00057.2007

Developmental aspects of the fetal renal response to exogenous arginine vasopressin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00057.2007

An oxytocin receptor antagonist (atosiban) in the treatment of preterm labor: a randomized, double-blind, placebo-controlled trial with tocolytic rescue

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00057.2007

SSR126768A (4-chloro-3-[(3R)-(+)-5-chloro-1-(2,4-dimethoxybenzyl)-3-methyl-2-oxo-2,3-dihydro-1H-indol-3-yl]-N-ethyl-N-(3-pyridylmethyl)-benzamide, hydrochloride): a new selective and orally active oxytocin receptor antagonist for the prevention of p

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00057.2007

Synthesis of oxytocin analogues with replacement of sulfur by carbon gives potent antagonists with increased stability

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00057.2007

Expression and localization of human oxytocin receptor mRNA and its protein in chorion and decidua during parturition

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00057.2007

Spontaneous contractions of myometrium from humans, non-human primate and rodents are sensitive to selective oxytocin receptor antagonism in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00057.2007

2,5-Diketopiperazines as potent and selective oxytocin antagonists 1: Identification, stereochemistry and initial SAR.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00057.2007

Identification of potent and selective oxytocin antagonists. Part 2: further investigation of benzofuran derivatives

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00057.2007

Structure-activity relationship investigations of a potent and selective benzodiazepine oxytocin antagonist

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00057.2007

10.1152/AJPREGU.00057.2007

21 January 2018

Identifiers

DOI

1 reference

3 August 2017

1 reference